title: Combined treatment with thymosin alpha 1 and interferon enhances NK activity in immunosuppressed tumor bearing mice.
authors.affiliation: Department of Experimental Medicine and Biochemical Sciences, II University of Rome. Via Orazio Raimondo 00173 Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Pica
authors.forename: A
authors.initials: A
authors.lastname: Mastino
authors.forename: S
authors.initials: S
authors.lastname: Grelli
authors.forename: T
authors.initials: T
authors.lastname: Jezzi
authors.forename: C
authors.initials: C
authors.lastname: Favalli
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D003520:Cyclophosphamide / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D007165:Immunosuppression Therapy; D007372:Interferons / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D000077596:Thymalfasin; D013947:Thymosin / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D000276:Adjuvants, Immunologic; D013947:Thymosin; D003520:Cyclophosphamide; D007372:Interferons; D000077596:Thymalfasin